• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一种铂（II）金属嵌入剂的体内研究。

In vivo studies of a platinum(II) metallointercalator.

作者信息

Fisher Dianne M, Fenton Ronald R, Aldrich-Wright Janice R

机构信息

School of Chemistry, The University of Sydney, NSW 2006, Australia.

出版信息

Chem Commun (Camb). 2008 Nov 21(43):5613-5. doi: 10.1039/b811723c. Epub 2008 Sep 26.

DOI:10.1039/b811723c
PMID:18997969
Abstract

An in vivo study for determining the toxicity and efficacy of [Pt(S,S-dach)(phen)Cl(2).1.5H(2)O.0.5HCl (PHENSS) in female Specific Pathogen Free (SPF) Swiss nude mice bearing PC3 tumour xenografts revealed PHENSS to be non-toxic and effective in decreasing tumour growth.

摘要

一项关于测定[Pt(S,S-二氨基环己烷)(邻菲罗啉)氯(2).1.5水(2)氧.0.5盐酸(PHENSS)]对携带PC3肿瘤异种移植的雌性无特定病原体(SPF)瑞士裸鼠的毒性和疗效的体内研究表明，PHENSS无毒且能有效抑制肿瘤生长。

相似文献

1
In vivo studies of a platinum(II) metallointercalator.一种铂（II）金属嵌入剂的体内研究。
Chem Commun (Camb). 2008 Nov 21(43):5613-5. doi: 10.1039/b811723c. Epub 2008 Sep 26.
2
Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.新型二氨基环己烷铂肿瘤靶向给药系统AP5346的临床前疗效与药代动力学
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2248-54. doi: 10.1158/1078-0432.CCR-05-2169.
3
In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma.
Eur J Pharmacol. 2006 Nov 7;549(1-3):27-34. doi: 10.1016/j.ejphar.2006.08.015. Epub 2006 Aug 16.
4
Efficacy of new platinum analog DPPE in an orthotopic nude mouse model of human colon cancer.
Anticancer Res. 1999 Jan-Feb;19(1A):157-61.
5
[Antitumor activity of a new platinum complex (R)-(-)-2-aminomethylpyrrolidine (1,1-cyclobutane dicarboxylato) platinum (II) (DWA2114R) by its serial administration].新型铂配合物（R）-（-）-2-氨甲基吡咯烷（1,1-环丁烷二羧酸根）铂（II）（DWA2114R）连续给药的抗肿瘤活性
Gan To Kagaku Ryoho. 1989 May;16(5):2039-43.
6
Assessing the therapeutic and toxicological effects of cesium chloride following administration to nude mice bearing PC-3 or LNCaP prostate cancer xenografts.评估氯化铯对携带PC-3或LNCaP前列腺癌异种移植瘤的裸鼠给药后的治疗和毒理学效应。
Cancer Chemother Pharmacol. 2007 Nov;60(6):821-9. doi: 10.1007/s00280-007-0429-4.
7
The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators.辅助配体手性和菲咯啉官能团取代对铂（II）基金属嵌入剂细胞毒性的影响。
J Inorg Biochem. 2007 Jul;101(7):1049-58. doi: 10.1016/j.jinorgbio.2007.04.009. Epub 2007 May 4.
8
Antitumor activity of platinum(II) complexes with histamine and radioiodinated histamine in a transplantable murine adenocarcinoma model.铂（II）与组胺及放射性碘化组胺形成的配合物在可移植性小鼠腺癌模型中的抗肿瘤活性
Nucl Med Biol. 2008 Jul;35(5):605-13. doi: 10.1016/j.nucmedbio.2008.03.004.
9
Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.125I标记的针对雄激素受体的三链形成寡核苷酸对人前列腺癌异种移植瘤生长的抑制作用
Chin Med J (Engl). 2008 Nov 20;121(22):2284-9.
10
Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.抗肿瘤奥沙利铂/顺铂对接双核铂配合物的制备
Biomed Pharmacother. 2005 Jun;59(5):224-9. doi: 10.1016/j.biopha.2004.06.006.

引用本文的文献

1
Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity.轴向位置含有吲哚基衍生物 5-苯甲氧基吲哚-3-乙酸的铂（IV）前药表现出显著的抗癌活性。
Int J Mol Sci. 2024 Feb 11;25(4):2181. doi: 10.3390/ijms25042181.
2
Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents.萘普生和阿西美辛的多功能铂（IV）前药作为化学抗炎剂
Cancers (Basel). 2023 Apr 26;15(9):2460. doi: 10.3390/cancers15092460.
3
Bioactive Platinum(IV) Complexes Incorporating Halogenated Phenylacetates.
含卤素苯乙酸的生物活性铂（IV）配合物。
Molecules. 2022 Oct 21;27(20):7120. doi: 10.3390/molecules27207120.
4
Transition Metal Intercalators as Anticancer Agents-Recent Advances.过渡金属嵌入剂作为抗癌剂——最新进展
Int J Mol Sci. 2016 Oct 31;17(11):1818. doi: 10.3390/ijms17111818.
5
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.下一代铂类药物：靶向铂（II）剂、纳米颗粒递送及铂（IV）前药
Chem Rev. 2016 Mar 9;116(5):3436-86. doi: 10.1021/acs.chemrev.5b00597. Epub 2016 Feb 11.
6
A dual-targeting, p53-independent, apoptosis-inducing platinum(II) anticancer complex, [Pt(BDI(QQ))]Cl.一种双靶向、不依赖p53、诱导凋亡的铂（II）抗癌配合物，[Pt(BDI(QQ))]Cl。
Metallomics. 2014 Mar;6(3):437-43. doi: 10.1039/c3mt00364g. Epub 2014 Feb 11.
7
Identification of the molecular mechanisms underlying the cytotoxic action of a potent platinum metallointercalator.一种强效铂金属嵌入剂细胞毒性作用的分子机制鉴定
J Chem Biol. 2012 Apr;5(2):51-61. doi: 10.1007/s12154-011-0070-x. Epub 2011 Dec 6.
8
Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator.一种新型铂（II）金属嵌入剂的体外与体内抗肿瘤效果差异。
Invest New Drugs. 2011 Dec;29(6):1164-76. doi: 10.1007/s10637-010-9461-z. Epub 2010 Jun 10.